OTC:PTPI | Free Cash Flow | Petros Pharmaceuticals, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$784,272.00
2025-12-31-$933,544.00
2025-03-31-$1.66M
2024-12-31$965,405.00$5,449.00$959,956.00
2024-03-31-$1.13M
2023-12-31-$2.26M
2023-03-31-$748,363.00
2022-12-31-$1.57M
2022-03-31-$5.28M
2021-12-31-$8.3M
2021-03-31-$446,581.00
2020-12-31-$4.52M$0.00-$4.52M
2020-03-31-$2.38M$4,429.00-$2.38M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$6.73M
2024-12-31-$2.6M$24,587.00-$2.63M
2023-12-31-$7.63M
2022-12-31-$12.8M
2021-12-31-$11.86M
2020-12-31-$15.31M$4,633.00-$15.31M